News
GLP-1 RAs used by adults with type 2 diabetes and obesity is linked to lower risk for dementia, stroke, and mortality vs ...
New weight management drugs could be used to create a global metabolic health revolution and improve longevity, if investment ...
2h
TAG24 on MSNWeight loss jabs linked to lower dementia and stroke riskWeight loss jabs may offer a protective effect against dementia and stroke, according to a new study.People with type 2 diabetes and obesity who are taking the drugs are also less likely to die ...
“Weight loss quality is a new concept….The discussion no longer revolves around the lack of adequate efficacy but rather ...
British Columbia's Ministry of Health is limiting the sales of two more diabetes drugs in an attempt to curb their off-label ...
Thousands of adults age 50-plus are diagnosed with HIV every year, but an expanding menu of medications can help prevent ...
Pennington Biomedical researchers and their collaborators observed decreased activity in the brain regions responsible for ...
FAT jabs have taken the world by storm, offering millions of people with excess weight a chance of a new life. The ‘King Kong ...
Weight-loss injections, including popular drugs like Wegovy and Mounjaro, may offer a protective shield against serious ...
Benefits were most prominent among women, patients older than 60 and those with a body mass index of 30 to 40.
For people who are obese and have type 2 diabetes, using Ozempic and other GLP-1 agonist drugs cuts the all-cause mortality rate by 30%, according to a new Use of GLP-1 agonists also cut the risk that ...
Fractyl Health offers a high-risk, high-reward setup with a near-term binary catalyst in the REMAIN-1 cohort data expected Q3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results